Legislative Activity

The "Personalized Care Act of 2025" expands Health Savings Account (HSA) eligibility, increases contribution limits, and allows HSA funds to be used for a broader range of healthcare expenses, including health plan premiums and healthcare sharing ministry fees. It also reduces the penalty for non-qualified HSA distributions and clarifies the treatment of medical care service arrangements and periodic provider fees. These changes aim to provide individuals with greater flexibility and control over their healthcare spending and coverage.

The "Second Chance for Moms Act of 2025" requires a warning label on mifepristone indicating its effects may be reversed with progesterone, potentially increasing fetal survival, and provides a hotline number for further information. It also directs the Secretary to establish a 24/7 toll-free hotline for women seeking to reverse the effects of mifepristone, offering referrals exclusively to healthcare providers who offer abortion pill reversal.

The "PROTECTS Act of 2025" prohibits federal funds from being used for gender transition procedures for individuals under 18, including surgeries and hormone therapies, with exceptions for certain medical conditions and genetic disorders. The bill defines "sex" as biologically determined male or female based on reproductive systems.

The "Dignity for Aborted Children Act" requires abortion providers to offer patients the option to take possession of fetal remains for burial or cremation, or to have the provider arrange for interment or cremation. Abortion providers must obtain consent, maintain records, and submit annual reports on abortion procedures and fetal tissue disposal. Non-compliance can result in significant penalties, but patients are protected from prosecution.

The "Safeguarding American Workers Benefits Act" amends the Internal Revenue Code to modify Social Security number (SSN) requirements for the Child Tax Credit and the Earned Income Tax Credit. It mandates that to claim these credits, the SSN must be issued by the Social Security Administration to a U.S. citizen or someone authorized to work in the U.S. These modifications will be effective for taxable years beginning after December 31, 2025.

The "CBO Show Your Work Act" mandates the Congressional Budget Office (CBO) to publicly release the fiscal, policy, and data models used for cost estimates of legislation, along with any updates. This allows for transparency and replication of CBO's analyses by external parties. The CBO must also disclose data, programs, assumptions, and computational details used in preparing cost estimates, while protecting confidential data by providing detailed variable lists, statistics, and contact information for data access.

The "Teleabortion Prevention Act of 2025" prohibits healthcare providers from performing chemical abortions without being physically present to examine the patient, administer the medication, and schedule a follow-up visit. Violators may face fines and imprisonment, but the patient cannot be prosecuted. An exception is included if the abortion is necessary to save the mother's life.

The "No Abortion Coverage for Medicaid Act" seeks to codify the Hyde Amendment by ensuring that federal Medicaid funds are not used for abortions or health coverage that includes abortion services. This includes prohibiting the use of federal funds for travel or lodging related to obtaining an abortion. Exceptions are made only in cases of rape, incest, to save the mother's life, or for the treatment of a miscarriage or ectopic pregnancy.

The "Prohibiting Abortion Industry's Lucrative Loopholes Act" amends the Public Health Service Act to broaden the definition of "valuable consideration" concerning the sale or transfer of human fetal tissue. This bill expands the definition of prohibited compensation to include various forms of payment, debt forgiveness, gifts, reduced costs, and reimbursements related to the handling and transfer of fetal tissue. The goal of the act is to prevent any potential financial incentives related to abortion and fetal tissue transfer.

The "Life at Conception Act" declares that the right to life, as guaranteed by the Constitution, is vested in each human being, both born and preborn, from fertilization onward. This act defines "human being" as every member of the species homo sapiens at all stages of life. Notably, the act specifies that no woman shall be prosecuted for the death of her unborn child.

The "Born-Alive Abortion Survivors Protection Act" ensures that infants born alive after an abortion receive the same medical care as any other newborn, mandating immediate hospitalization and requiring healthcare practitioners to report any failures to comply. Violators face fines, imprisonment, and potential prosecution for homicide or attempted homicide, while the mother of the child cannot be prosecuted. The bill also allows the woman who had the abortion to file a civil action against anyone who violated the act. It defines abortion and attempts at abortion, and renames "Partial-Birth Abortions" to "Abortions" in relevant sections of the U.S. Code.

The FAIR Act of 2025 prohibits the federal government and recipients of federal aid from discriminating or granting preferential treatment based on race, color, or national origin in federal contracts, employment, and programs. It requires federal agencies to review and update their policies to comply with the Act and allows individuals harmed by violations to sue for relief. The Act does not retroactively affect pending legal cases or existing contracts and subcontracts. It also clarifies that the Act does not alter existing immigration or nationality laws.

This bill expresses support for designating January 26 - February 1, 2025, as "National School Choice Week" to recognize the importance of diverse K-12 education options and the role of parents in choosing the best learning environment for their children. It encourages raising awareness about the benefits of educational choice and congratulates those involved in education.

The "End the Deep State Act" aims to create a new category of federal employees ("Schedule PolicyCareer") who are in confidential, policy-related roles, ensuring they can be hired and retained based on their alignment with the President's policies. It directs agencies to review positions and reclassify suitable roles under this new schedule, while also revoking a prior Executive Order that limited the ability to remove employees. The Act seeks to make federal employees more accountable to the President and ensure the President can depend on federal employees in policy-related roles. This bill would allow for the firing of federal employees who do not implement administration policies to the best of their ability, in accordance with their constitutional oath.

The "Promoting Domestic Energy Production Act" revises the tax treatment of intangible drilling and development costs for oil and gas operations. It modifies how these costs are handled when calculating adjusted financial statement income, aligning depreciation and expense deductions more closely with taxable income standards. These adjustments impact depreciation deductions under section 167 and deductions for expenses under section 263(c) of the Internal Revenue Code. The changes will be effective for taxable years starting after December 31, 2025.

The "SAVE Moms and Babies Act of 2025" prohibits the approval of new abortion drugs and restricts the use of previously approved abortion drugs by limiting label changes, mandating in-person dispensing by certified healthcare practitioners, and requiring comprehensive reporting of adverse events. It defines key terms such as "abortion drug," "adverse event," and "unborn child," and it rescinds conflicting investigational use exemptions three years after enactment. This bill aims to ensure patient safety and regulatory oversight in the use of abortion drugs.

The Federal Insurance Office Elimination Act eliminates the Federal Insurance Office and the position of its Director within the Department of the Treasury. It transfers certain responsibilities and authorities previously held by the office to other entities, such as the Secretary of the Treasury and the Board of Governors. The act also makes related amendments to the Dodd-Frank Wall Street Reform and Consumer Protection Act and the Economic Growth, Regulatory Relief, and Consumer Protection Act to reflect these changes. This bill does not repeal or limit the Secretary of the Treasury's authority over insurance-related matters.

The "Main Street Tax Certainty Act" amends the Internal Revenue Code of 1986 to permanently extend the deduction for qualified business income. This removes the previous expiration date, providing long-term tax certainty for eligible businesses. The change applies to taxable years beginning after December 31, 2025.

This bill nullifies the FDA's January 2023 modifications to the risk evaluation and mitigation strategy (REMS) for mifepristone, an abortion pill. It also prevents the Secretary of Health and Human Services from creating or enforcing similar regulations related to mifepristone's distribution.

The "No Taxpayer Funding for the U.N. Population Fund Act" prohibits U.S. taxpayer dollars from being contributed to the United Nations Population Fund. This includes both direct and indirect contributions from the Department of State, as well as any other federal department or agency.